Innate Pharma S.A. logo

Innate Pharma S.A.

EPA:IPH.PA

Overview | Financials
Company Name Innate Pharma S.A.
Symbol IPH.PA
Currency EUR
Price 2.05
Market Cap 165,945,091
Dividend Yield 0%
52-week-range 1.862 - 2.8
Industry Biotechnology
Sector Healthcare
CEO Dr. Mondher Mahjoubi M.D.
Website https://www.innate-pharma.com

An error occurred while fetching data.

About Innate Pharma S.A.

Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well

Related Stocks

Carmat SA logo

Carmat SA

ALCAR.PA

1.792 EUR

Transgene SA logo

Transgene SA

TNG.PA

1.022 EUR

Eurobio Scientific Société anonyme logo

Eurobio Scientific Société anonyme

ALERS.PA

24.95 EUR

Laboratorio Reig Jofre, S.A. logo

Laboratorio Reig Jofre, S.A.

RJF.MC

2.73 EUR

Biosynex SA logo

Biosynex SA

ALBIO.PA

4.225 EUR

Prim, S.A. logo

Prim, S.A.

PRM.MC

10.8 EUR

Malin Corporation plc logo

Malin Corporation plc

MLC.IR

6.15 EUR

Median Technologies SA logo

Median Technologies SA

ALMDT.PA

4 EUR

Bastide Le Confort Médical SA logo

Bastide Le Confort Médical SA

BLC.PA

20.1 EUR

Nanobiotix S.A. logo

Nanobiotix S.A.

NANO.PA

4.646 EUR

Financials

Numbers are in millions USD

Numbers are in millions USD